BE844472A - Procede de preparation de 1,2,3,4-tetrahydroisoquinoleines nouveaux produits ainsi obtenus et leur utilisation pour leur activite de relaxation sur les muscles lisses - Google Patents

Procede de preparation de 1,2,3,4-tetrahydroisoquinoleines nouveaux produits ainsi obtenus et leur utilisation pour leur activite de relaxation sur les muscles lisses

Info

Publication number
BE844472A
BE844472A BE169196A BE169196A BE844472A BE 844472 A BE844472 A BE 844472A BE 169196 A BE169196 A BE 169196A BE 169196 A BE169196 A BE 169196A BE 844472 A BE844472 A BE 844472A
Authority
BE
Belgium
Prior art keywords
tetrahydroisoquinoleins
preparation
new products
smooth muscles
relaxation activity
Prior art date
Application number
BE169196A
Other languages
English (en)
French (fr)
Inventor
T Kishimoto
I Ueda
M Kato
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE844472A publication Critical patent/BE844472A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE169196A 1975-07-28 1976-07-23 Procede de preparation de 1,2,3,4-tetrahydroisoquinoleines nouveaux produits ainsi obtenus et leur utilisation pour leur activite de relaxation sur les muscles lisses BE844472A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31570/75A GB1553230A (en) 1975-07-28 1975-07-28 1 - aminomethyl - 6,7-dihydroxy - 1,2,3,4-tetrahydroisoquinolines and the preparation thereof

Publications (1)

Publication Number Publication Date
BE844472A true BE844472A (fr) 1977-01-24

Family

ID=10325102

Family Applications (1)

Application Number Title Priority Date Filing Date
BE169196A BE844472A (fr) 1975-07-28 1976-07-23 Procede de preparation de 1,2,3,4-tetrahydroisoquinoleines nouveaux produits ainsi obtenus et leur utilisation pour leur activite de relaxation sur les muscles lisses

Country Status (19)

Country Link
US (1) US4096263A (xx)
JP (1) JPS5217477A (xx)
AR (1) AR212174A1 (xx)
AT (1) AT358588B (xx)
AU (1) AU506715B2 (xx)
BE (1) BE844472A (xx)
CA (1) CA1068276A (xx)
CH (1) CH623310A5 (xx)
DE (1) DE2633692A1 (xx)
DK (1) DK143750C (xx)
ES (1) ES450206A1 (xx)
FR (1) FR2319357A1 (xx)
GB (1) GB1553230A (xx)
IE (1) IE43502B1 (xx)
IT (1) IT1063405B (xx)
MX (1) MX3999E (xx)
NL (1) NL7608319A (xx)
SE (1) SE423233B (xx)
ZA (1) ZA764508B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5734275B2 (xx) * 1973-07-30 1982-07-22
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
JP4889463B2 (ja) * 2006-12-07 2012-03-07 株式会社椿本バルクシステム チェーンコンベヤ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3389140A (en) * 1966-05-16 1968-06-18 Bristol Myers Co 1-beta-arylaminoethyl-2-methyl-6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinolines
JPS5734275B2 (xx) * 1973-07-30 1982-07-22
US3963725A (en) * 1973-07-20 1976-06-15 Fujisawa Pharmaceutical Co., Ltd. 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof
US3994891A (en) * 1974-12-20 1976-11-30 Armour Pharmaceutical Company Tetrahydroisoquinoline compounds

Also Published As

Publication number Publication date
AU506715B2 (en) 1980-01-24
DE2633692A1 (de) 1977-02-17
ES450206A1 (es) 1977-11-16
SE423233B (sv) 1982-04-26
ZA764508B (en) 1977-07-27
FR2319357B1 (xx) 1978-11-17
CH623310A5 (xx) 1981-05-29
DK143750B (da) 1981-10-05
GB1553230A (en) 1979-09-26
NL7608319A (nl) 1977-02-01
DK336676A (da) 1977-01-29
IE43502L (en) 1977-01-28
AU1629076A (en) 1978-02-02
DK143750C (da) 1982-03-29
SE7608453L (sv) 1977-01-29
AT358588B (de) 1980-09-25
US4096263A (en) 1978-06-20
AR212174A1 (es) 1978-05-31
CA1068276A (en) 1979-12-18
ATA552076A (de) 1980-02-15
JPS5217477A (en) 1977-02-09
FR2319357A1 (fr) 1977-02-25
MX3999E (es) 1981-10-28
IE43502B1 (en) 1981-03-11
IT1063405B (it) 1985-02-11

Similar Documents

Publication Publication Date Title
BE860971A (fr) Procede de preparation de n,n'-methylenebis-(0,0-diaryl n-phosphonomethylglycinonitriles, nouveaux produits ainsi obtenus et leur utilisation
FR2345452A1 (fr) Procede de preparation d'arylmalonamido-1-oxadethiacephalosporines et nouveaux produits ainsi obtenus, a activite antibacterienne
BE881014A (fr) Procede de preparation d'organopolysiloxanes, et produits ainsi obtenus
BE872210A (fr) Procede de preparation de nitrodiarylamines et nouveaux produits ainsi obtenus
BE856860A (fr) Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation
FR2306214A1 (fr) Procede de preparation de 17 a-ester-21-halopregnanes et nouveaux produits ainsi obtenus
FR2279720A1 (fr) Procede de preparation d'alkyltetracyclines et nouveaux produits obtenus
BE852708A (fr) Procede de preparation de bisimides et bisimides ainsi obtenus
FR2274299A1 (fr) Procede de preparation de 7b-acylamino-7a-alcoxycephalosporines et 6b-acylamino-6a-alcoxy-penicillines, nouveaux produits obtenus et leur application
FR2276828A1 (fr) Procede de production de derives d'alkylamino-glucopyranoside, nouveaux produits ainsi obtenus et leur utilisation pour leur activite anticancer
BE844458A (fr) Procede d'hydroxylation de composes aromatiques, et produits ainsi obtenus
BE889729A (fr) Procede de preparation de n-(alkulaminoalkyl)-acrylamides et produits ainsi obtenus
FR2348936A1 (fr) Procede de preparation de copolymeres de l'acrylonitrile et produits obtenus
BE854167A (fr) Procede de preparation de derives de n-phosphono-methylglycine, nouveaux produits ainsi obtenus et leur utilisation comme herbicides
FR2306994A1 (fr) Procede de preparation de phosphonate et nouveaux produits ainsi obtenus
FR2317924A1 (fr) Procede de production de derives d'ortho-aminobutyrophenone, nouveaux produits ainsi obtenus et leur utilisation comme agents analgesiques et antipsychose
FR2306702A1 (fr) Procede de preparation de sterolglucosides facilement absorbable et nouveaux produits ainsi obtenus
BE879830A (fr) Procede de preparation de 1,2,3-thiadiazol-5-yl-urees et produits obtenus
BE858388A (fr) Procede pour la preparation de pyridines substituees et produits obtenus
FR2319357A1 (fr) Procede de preparation de 1, 2, 3, 4-tetrahydroisoquinoleines, nouveaux produits ainsi obtenus et leur utilisation pour leur activite de relaxation sur les muscles lisses
FR2290206A1 (fr) Procede de preparation de 1,2,3,4-tetrahydroisoquinoleines, nouveaux produits ainsi obtenus et leur utilisation comme agents a activite de relaxation sur les muscles lisses
FR2328692A1 (fr) Procede pour la preparation d'alpha, omega-diamines aliphatiques, et produits obtenus
FR2314672A1 (fr) Procede de traitement de l'avoine et produits obtenus
BE844745A (fr) Procede de preparation de derives de 5-andro-sten-17-one, produits ainsi obtenus et leur utilisation
FR2327989A1 (fr) Procede de preparation de n-(3,5-dihalophenyl) cyclopropanedicarboximides, nouveaux produits ainsi obtenus et leur utilisation dans des compositions microbicides

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO. LTD

Effective date: 19850731